A Study Evaluating the Effect of BRIUMVI® (Ublituximab) on Pregnancy and Infant Outcomes in Participants With Multiple Sclerosis (MS)
Clinical trial NCT06433765 · RECRUITING
Trial details
- NCT number
- NCT06433765
- Sponsor
- TG Therapeutics, Inc.
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-06-01
- Primary completion
- 2035-03-31
- Enrollment
- 728
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.